Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort

BACKGROUND: Despite widespread use in HIV and hepatitis B virus (HBV) infection, the effectiveness of tenofovir (TDF) has not been studied extensively outside of small HBV-HIV coinfected cohorts. We examined the effect of prior lamivudine treatment (3TC) and other factors on HBV DNA suppression with...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kim, H. Nina, Rodriguez, Carla V., Van Rompaey, Stephen, Eron, Joseph J., Thio, Chloe L., Crane, Heidi M., Overton, Edgar T., Saag, Michael S., Martin, Jeffrey, Geng, Elvin, Mugavero, Michael, Rodriguez, Benigno, Mathews, W. Christopher, Boswell, Stephen, Moore, Richard, Kitahata, Mari M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981874/
https://ncbi.nlm.nih.gov/pubmed/24500175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000126
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires